Current methods for estimating 5'-nucleotidase activity in human serum are critically discussed. The requirements for specificity in the assay procedure are re-emphasised, special consideration being given to the absolute concentrations as well as the molar ratios of true and alternative substrates. Substrate-inhibition, described in a previous Report is believed to be due to a non-linear relationship between AMP concentration and optical density above 0.1 mM.
In the past three years, we have described four methods for the determination of 5'-nucleotidase (EC 3.1.3.5) in human serum. The first is based upon magnesium activation (1) . In two further reports, the S'-nucleotidase was coupled with adenosine deaminase (EC 3.5.4.4) and rate measurements were made at 265 nm (2) and at 340 nm (3). Finally, in a coupled reaction with adenosine deaminase the BERTHELOT reaction was used for the colorimetric measurement of the ammonia produced (4). The last three techniques take advantage of a high concentration of /?-glycerophosphate to suppress hydrolysis of 5'-AMP by non-specific alkaline phosphatase (5, 6) . Concurrently, and in a number of independent publications, a colorimetric method similar to that of reference (4) has been presented by PERSIJN, VAN DER SLIK, . The last of these papers (10) contains a number of statements which we consider to be in need of clarification. We shall attempt to summarise the requirements for specificity in the determination of S'-nucleotidase activity.
Requirements for specificity
Substrate Concentration Table 1 of reference (10) draws attention to the small substrate concentrations used in spectrophotometric assays relative to those used in colorimetric assays. Our spectrophotometric assay (2) employs only 20 / of serum in place of 100 (7) and the reaction is monitored over 20 min. instead of 60min. (7) that in the course of the assay, the method in reference (7) consumes fifteen times more substrate than our spectrophotometric method. However, this in no way justifies the excessively high substrate concentration (5 mn) used by these authors since their own data ( Fig. 3 of reference 10) show that 1 mM AMP is more than sufficient to sustain optimal activity. Their complaint that optimal substrate concentration cannot be evaluated by the spectrophotometric assay is surprising, since we have already published a value for K m of S'-nucleotidase based upon this assay (4). We have repeated this determination in quadruplicate at five concentrations of AMP, and by application of a computerised statistical analysis of the data (11) derived a value of 9.82 ^moles/litre (Standard Error 1.15 /onoles) which is in good agreement with the figure of 11 /jmoles/litre obtained by LEYBOLD and colleagues (12, 13) . This means that our substrate concentration (0.1 ) theoretically supports 91% of V max , and in practise this figure is closer to 97% (12). Reference (10) cites a personal communication by one of us (D. M. G.) to the effect that substrate inhibition takes place above 0.12 mM AMP. This statement has never been made by us; on the contrary, we have published substrate-velocity curves (3) showing under somewhat different reaction conditions a plateau in S'-nucleotidase activity between 0.167 mM and 0.5 mM provided that full suppression of non-specific alkaline phosphatase is achieved (Fig. 1) . LEYBOLD and colleagues (12, 13) claimed that such substrate inhibition did in fact occur, but they were working at optical densities greater than 2.7. AMP and inosine solutions obey the BEER-LAMBERT Law at 265 nm and pH 7.9 to O. D. 1.9; beyond this, the relationship is nonlinear, and complex calibration curves using both AMP and inosine are needed to convert O. D. changes to the actual amount of substrate consumed. It is probable that this necessity was not realised by LEYBOLD King Units per 100 ml (19).
and colleagues, leading to a progressive underestimate of enzyme' activity as substrate, and therefore, Ε 2β5 was increased.
Alternative Substrate Concentration In our original description of the phenomenon of enzyme diversion (5), and subsequently (6, 14), we have emphasised the importance of a high molar ratio of the substrate for non-specific phosphatase relative to that of the specific phosphatase being measured. This ratio has never been less than 100:1 for any of the S'-nucleotidase methods proposed by us. Yet the ratio of phenyl phosphate to AMP is only 8:5 in references (9, 10). This ratio is much too low for adequate suppression of alkaline phosphatase activity (Fig. 2) . It is clear from Figs. 1 and 2 of reference (9) that increasing suppression of serum alkaline phosphatase takes place when the phenyl phosphate concentration is increased from 8 HIM (the concentration used by these authors in their standard procedure ) to 25 mM. A further contribution towards improving specificity would be achieved, by lowering the AMP concentration to 1 mM; this would also reduce the value of the bknk due to the presence of free adenosine in the substrate, which can contribute as much as 50% of the total O. D. of normal sera (15).
Purity of adenosine deaminase Reference (10) indulges in prolonged speculative calculations and theorises on the effect that the contamination of commercial adenosine deaminase by AMP deaminase might have on the various methods. Our experiments on this point are presented in Table 1 which shows that when adenosine deaminase is used in 16-fold excess over the amount we normally employ, an apparent increase in S'-nucleotidase activity equivalent to 3 IU// would be obtained if /?-glycerophosp hate were omitted. This shows that the contaminating . JE = Etest-Ebiank enzyme in commerical adenosine deaminase preparations, previously thought to be AMP deaminase (7), is more probably a non-specific phosphatase, and is inhibited by the -glycerophosphate which has been an integral part of all our S'-nucleotidase assays utilising adenosine deaminase. In any case, the pH optimum of AMP deaminase, is 5.9 (16), which is far removed from pH 7.9 at which our assay is conducted; and we have always recommended a system of reagent checks with each batch of determinations (3, 4).
pH of Assay PERSIJN and colleagues employ a buffer at pH 7.5 in their assay. They have not published a pH-activity curve using their method. We have shown, with two methods, that the pH optimum for serum S'-nucleotidase is 7.9 (1, 4) and our assays are conducted at this pH.
Precision
The authors of reference (10) complain that we have not stated the precision of our spectrophotometric method in the normal range. Previously (2) we gave an estimate of precision based upon replicate analyses of a serum with moderately raised activity. The precision of this method in the normal range was evaluated by calculating the standard deviation of pooled duplicates according to PEARSON (17) using the data routinely accumulated in our laboratory, the value being 1.9 IU//. This approximates to more than twice the variance claimed by the authors of reference (7) who have not, however, given this information for their most recent modification (9). Sensitivity Reference (10) Table 3 gives a misleading impression of the relative sensitivities of our spectrophotometric method (2) and that of the former authors. When the data are expressed as theoretical O. D. change per hour per ml of serum, the spectrophotometric methods (2, 14) are 50% more sensitive than the colorimetric method of PERSIJN (7). Our own colorimetric method is, using the same criteria, the most sensitive yet described (4), but requires correction for inhibition of the BERTHELOT reaction caused by the synergistic action of serum and EDTA. PERSIJN and colleagues have not satisfactorily met our criticism that they have failed to recognise this inhibition. Until now, they have presented data for the recovery of adenosine (7) which averaged 98.1% (standard deviation 5.1%), and made inferences based upon linearity between serum volume and O. D. (10, Fig. 1 ) and EDTA concentration (10, Fig. 2 ). In none of this work is it clearly stated whether ammonia standards were employed. Using their method exactly as published (7-9), we found a consistent difference averaging 5% between the O. D. generated by aqueous ammonia in the presence and absence of 100 μΐ serum (Fig. 3) after making allowance for the ammonia content of the serum. This is additional to the inhibition due to veronal and EDTA, amounting to approximately 5%, but allowed for by the device of preparing adenosine standards in veronal and including EDTA during colour development. With a fixed concentration of ammonia, increasing the volume of serum in the reaction mixture causes a linear decrease in O. D. (Fig. 4) ; this line was derived statistically from a least-squares fit, and the inhibition with 100 μΐ serum was 4.5%. This is much less than the inhibition of about 15% occurring in our method (4). Since we use the concentrated reagents of CHANEY and MARBACH (16) whereas PERSIJN and colleagues use these reagents in the dilute form, the concentration of EDTA and serum and therefore the extent of inhibition is greater in our system, but at the same time sensitivity is also increased. (7) in presence of buffer and Mg-n-but varying volume of pooled human serum, with total volume of reaction mixture maintained constant
Tissue Specificity In Fig. 2 human hepatic S'-nucleotidase, present in the bile, shows, under the conditions of PERSIJN (7-10), little increase in activity with increase in 5'-AMP concentration. Hydrolysis of 5'-AMP is constant when the molar ratio of 5'-AMP to phenyl phosphate is held constant at 5:8. When phenyl phosphate is held constant at 8 mM, increased hydrolysis of 5'-AMP occurs with increasing concentration of the latter since the alteration in the ratio favours its hydrolysis by nonspecific alkaline phosphatase. The two lines meet when the absolute concentrations of phenyl phosphate and 5
; -AMP are 8 mM and 5 mM respectively. The hydrolysis of 5'-AMP in the presence of 25 mM phenyl phosphate is less than in the previous two cases, is less susceptible to changes in 5'-AMP concentration favouring hydrolysis of the latter by alkaline phosphatase, and thus provides a more accurate measure of true 5'-nucleotidase activity. The results for the intestinal and bone preparations lead to a similar interpretation. It will however be apparent that these preparations differ in the ratio of true 5'-nucleotidase to alkaline phosphatase present in the material; in the affinity of its alkaline phosphatase for 5'-AMP (intestinal phosphatase having the highest affinity); and in the susceptibility of its alkaline phosphatase to phenyl phosphate -induced suppression of 5'-AMP hydrolysis (bone phosphatase being least susceptible). This last point accords with the previously-documented resistance of human bone phosphatase to -glycerophosphate-induced suppression of 5'-AMP hydrolysis (5) .
Conclusions
In our view, the spectrophotometric assay at 265 nm (2) is the most specific method currently available. The spectrophotometric assay at 340 nm (3) is less sensitive, and the reagents are more expensive, but it is potentially capable of adaptation to automatic analysis. The method described by us (4) is the most sensitive colorimetric procedure and is very suitable for paediatric work, but a substantial correction for colour inhibition is needed. The method of PERSIJN and colleagues (7-10) requires a much smaller correction for colour inhibition, and in practise this could virtually be ignored, but it employs five times as much serum and is not well suited to paediatric work. It could be very useful in adult work if the authors would modify their concentrations of true and alternative substrates in accordance with the advice we have offered.
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